The Journal of Physiology,
Год журнала:
2024,
Номер
602(15), С. 3621 - 3639
Опубликована: Июль 9, 2024
Growing
evidence
supports
the
role
of
gut
microbiota
in
chronic
inflammation,
insulin
resistance
(IR)
and
sex
hormone
production
polycystic
ovary
syndrome
(PCOS).
Adropin
plays
a
pivotal
regulation
glucose
lipid
metabolism
is
negatively
correlated
with
IR,
which
affects
intestinal
hormones.
However,
effect
adropin
administration
PCOS
has
yet
to
be
investigated.
The
present
study
aimed
assess
effects
on
letrozole
(LTZ)-induced
rats
potential
underlying
mechanisms.
experimental
groups
were
normal,
adropin,
LTZ
+
adropin.
At
end
experiment,
significantly
ameliorated
PCOS,
as
evidenced
by
restoring
normal
ovarian
structure,
decreasing
theca
cell
thickness
antral
follicles,
well
serum
testosterone
luteinizing
levels
hormone/follicle-stimulating
ratios,
at
same
time
increasing
granulosa
oestradiol
follicle-stimulating
levels.
ameliorating
could
attributed
its
hormone-binding
globulin,
key
steroidogenic
genes
STAR
CYP11A1,
profile,
metabolites-brain-ovary
axis
components
(short
chain
fatty
acids,
free
acid
receptor
3
peptide
YY),
permeability
marker
(zonulin
tight
junction
protein
claudin-1),
lipopolysaccharides/Toll-like
4/nuclear
factor
kappa
B
inflammatory
pathway
oxidative
stress
makers
(malondialdehyde
total
antioxidant
capacity).
In
conclusion,
promising
therapeutic
regulating
steroidogenesis,
redox
homeostasis.
KEY
POINTS:
treatment
reversed
endocrine
morphology
disorders
regulated
steroidogenesis
globulin
PCOS.
improved
profile
decreased
modulated
gut-brain-ovary
YY)
barrier
integrity,
suppressed
signalling
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(14), С. 4243 - 4243
Опубликована: Июль 20, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
and
polycystic
ovary
syndrome
(PCOS)
are
prevalent
conditions
that
have
been
correlated
with
infertility
through
overlapped
pathophysiological
mechanisms.
MASLD
is
associated
metabolic
considered
among
the
major
causes
of
chronic
disease,
while
PCOS,
which
characterized
by
ovulatory
dysfunction
hyperandrogenism,
one
leading
female
infertility.
The
links
between
PCOS
not
yet
fully
elucidated,
insulin
resistance,
hyperandrogenemia,
obesity,
dyslipidemia
being
key
pathways
contribute
to
lipid
accumulation,
inflammation,
fibrosis,
aggravating
dysfunction.
On
other
hand,
exacerbates
resistance
dysregulation
in
women
creating
a
vicious
cycle
progression.
Understanding
intricate
relationship
crucial
improving
clinical
management,
collaborative
efforts
different
medical
specialties
essential
optimize
fertility
health
outcomes
individuals
PCOS.
In
this
review,
we
summarize
complex
interplay
highlighting
importance
increasing
attention
prevention,
diagnosis,
treatment
both
entities.
Current Nutrition Reports,
Год журнала:
2025,
Номер
14(1)
Опубликована: Янв. 3, 2025
Abstract
Purpose
of
Review
Polycystic
Ovary
Syndrome
(PCOS)
is
a
complex
endocrine
disorder
with
several
causal
pathways
including
impaired
glucose
tolerance,
insulin
resistance
(IR),
compensatory
hyperinsulinemia
and
excess
androgens
(hyperandrogenism).
This
heterogeneous
condition
causes
range
reproductive,
metabolic
psychological
implications,
the
severity
which
can
differ
between
individuals
depending
on
factors
such
as
age,
diet,
ethnicity,
genetics,
medication,
contraceptive
use,
adiposity,
Body
Mass
Index
(BMI).
Recent
Findings
Dietary
interventions
that
focus
low
glycaemic
index
control
are
an
efficient
first-line
dietary
solution
for
management
tolerance
IR,
subsequently
improves
weight
management,
quality
life
PCOS-related
symptoms
in
this
condition.
Summary
review
aims
to
explore
relevance
nutrition
more
specifically,
association
load
PCOS,
well
assess
potential
benefits
manipulating
those
indexes
approach
syndrome.
Journal of Research in Medical Sciences,
Год журнала:
2025,
Номер
30(1)
Опубликована: Янв. 1, 2025
Background:
The
objective
of
this
study
was
to
compare
the
effects
early
time-restricted
eating
(eTRE)
and
eTRE
plus
probiotic
supplementation
daily
caloric
restriction
(DCR)
alone
in
terms
biomarkers
oxidative
stress
(OS),
antioxidant
capacity,
inflammation,
blood
pressure
(BP)
obese
women
with
polycystic
ovary
syndrome
(PCOS).
Materials
Methods:
research
conducted
as
a
randomized,
parallel,
placebo-controlled
clinical
trial
an
8-week
follow-up
period.
Participants
were
randomly
assigned
one
three
groups:
14:10
(
n
=
30),
placebo
or
DCR
30).
At
beginning
8
weeks
intervention,
systolic
(SBP)
diastolic
BP,
OS
parameters
evaluated.
Results:
A
total
90
participants
(mean
age,
30.49
years
mean
weight,
81.45
kg)
enrolled
trial.
After
we
observed
SBP
significantly
decreased
both
+
group
(−0.31
mmHg
[95%
confidence
interval
(CI):
−0.55,
−0.07])
(−0.24
CI:
−0.43,
0.04]),
no
significant
differences
between
groups.
Moreover,
C-reactive
protein
(CRP)
levels
reduced
all
groups
P
<
0.005).
Total
capacity
(TAC)
also
showed
notable
improvement
0.012)
0.032).
However,
there
regarding
OS,
TAC,
CRP
markers.
Conclusion:
It
not
found
that
probiotics
intervention
resulted
improving
inflammatory,
than
standard
diet
among
PCOS.
present
did
reveal
improvements
inflammatory
markers,
either
combined
compared
diagnosed
Trial
Register
no:
IRCT20121110011421N5.
Food Science & Nutrition,
Год журнала:
2025,
Номер
13(4)
Опубликована: Март 26, 2025
This
study
aimed
to
investigate
the
associations
between
a
dietary
index
for
gut
microbiota
(DI-GM),
flavonoid
intake,
and
female
infertility,
while
exploring
age-specific
differences
in
these
relationships
identify
potential
strategies
infertility
prevention.
cross-sectional
focused
on
participants
aged
18-45
years,
with
data
obtained
from
2017-2018
cycle
of
National
Health
Nutrition
Examination
Survey
(NHANES).
Weighted
multivariable
logistic
regression
models
were
employed
examine
DI-GM,
self-reported
infertility.
Age-stratified
analyses
performed
evaluate
whether
varied
across
reproductive
life
stages.
Higher
DI-GM
scores
significantly
associated
reduced
risk
(aOR
=
0.30,
95%
CI:
0.13-0.71,
p
0.006),
strongest
protective
effects
observed
women
<
35
years
(Q3:
aOR
0.13,
0.03-0.58,
0.007;
Q4:
0.27,
0.09-0.77,
0.015).
Beneficial
also
showed
effect
0.75,
0.57-0.98,
0.036).
Among
≥
moderate
intake
(Q2)
significant
inverse
association
0.19,
0.06-0.66,
0.009).
Our
findings
reveal
novel
evidence
that
higher
are
linked
lower
patterns
observed.
younger
(<
years),
was
years.
These
underscore
personalized
targeting
composition
as
cost-effective
approaches
prevention
management
different
Life,
Год журнала:
2025,
Номер
15(4), С. 593 - 593
Опубликована: Апрель 3, 2025
The
gut
microbiome
has
emerged
as
a
novel
and
intriguing
focus
in
mood
disorder
research.
Emerging
evidence
demonstrates
the
significant
role
of
influencing
mental
health,
suggesting
bidirectional
communication
between
brain.
This
review
examines
latest
findings
on
gut–microbiota–brain
axis
elucidates
how
alterations
microbiota
composition
can
influence
this
axis,
leading
to
changes
brain
function
behavior.
Although
dietary
interventions,
prebiotics,
probiotics,
fecal
transplantation
have
yielded
encouraging
results,
advances
are
needed
establish
next-generation
approaches
that
precisely
target
neurobiological
mechanisms
disorders.
Future
research
must
developing
personalized
treatments,
facilitated
by
innovative
therapies
technological
progress,
which
account
for
individual
variables
such
age,
sex,
drug
history,
lifestyle.
Highlighting
potential
therapeutic
implications
targeting
microbiota,
emphasizes
importance
integrating
into
psychiatric
studies
develop
more
effective
treatment
strategies
European Journal of Medical and Health Research,
Год журнала:
2025,
Номер
3(2), С. 147 - 154
Опубликована: Март 27, 2025
The
microbes
associated
with
the
gut
are
called
microbiota.
There
about
1000
species
of
bacteria
weighing
up
to
1-2
kg
in
human
gut.
Microbial
diversity
increases
age
until
it
is
stable.
Humans
have
evolved
live
them
and
learned
play
their
role
body.
Dysbiosis
microbiota
causes
various
ailments,
disorders
diseases
humans.
And
all
this
due
increased
intestinal
permeability
caused
by
dysbiosis.
present
review
discusses
some
pathophysiological
clinical
symptoms
leaky
syndrome,
a
highly
controversial
but
logical
relevant
topic
medical
microbiology
gastroenterology